RecallDepth
Class II Terminated

Copaxone (glatiramer acetate injection), 20 mg/1 mL, packaged in 30 single use PRE-FILLED syringes and 33 Alcohol Preps (swabs) per box, Marketed by: TEVA Neuroscience, Inc., Kansas City, MO 64131; Distributed by: TEVA Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 68546-317-30

Company
Teva Pharmaceuticals Usa, Inc.
Recall Initiated
December 5, 2012
Posted
April 24, 2013
Recall Number
D-249-2013
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
6,692 boxes
Firm Location
Sellersville, PA, United States

Reason for Recall

Presence of Foreign Substance: Product is being recalled due to receiving an elevated number of patient complaints related to a visible presence of medical grade silicone oil essential to the functionality of the syringe and plunger stopper system.

Distribution

Nationwide

Lot / Code Info

Lot P53847, Exp 01/14

More recalls by Teva Pharmaceuticals Usa, Inc.

View all recalls by this company →

Other recent Class II Drug recalls